>>> Premier Foods notes no offer statement by McCormick; considers enhancing lon

Premier Foods notes no offer statement by McCormick; considers enhancing longer-term prospects by agreement signed with Nissin Foods
The Board of Premier Foods plc ("Premier Foods" or the "Company") notes the announcement by McCormick & Company, Inc ("McCormick") confirming that it does not intend to make an offer for the Company.

Premier Foods and its advisers have engaged extensively with McCormick to provide it with the information requested. The Board appreciates the open and constructive spirit in which the engagement with McCormick was conducted.

The Board sees a strong future for an independent Premier Foods, and believes that the foundations have been laid for significant growth and shareholder value creation.

Premier Foods has a valuable portfolio of market leading brands, extensive distribution across key retail channels, a well-invested manufacturing base and strong operational cash flows. Additionally the Company plans to accelerate its growth by executing its recently announced new strategic initiatives to leverage the Company's existing capabilities, infrastructure and brand equity so as to expand into new formats, channels and markets.

The Board also considers that the Company's longer-term prospects will be enhanced by the Co-Operation Agreement it has signed with Nissin Foods Holdings Co., Ltd. which will expand Premier Foods' range of growth opportunities

>>> Carrefour : Still a Buy For me another Broker pushing it see SocGen note

A new, compelling story still undervalued by the market – very good entry points

* Update The group is due to release its Q1 16 sales on Friday 15 April. In France, we
expect LFL sales growth of -1.0% for hypermarkets excluding the petrol/calendar effect,
reflecting a slight deterioration vs Q4 15 (-0.7%) due to tough comps. Outside France, the
group should benefit from firm sales trends in Spain and Italy (SGe respectively 2.5% and
3.0%), while Brazil should remain very resilient (SGe +9.0%). Although the road to recovery
should be long, we expect China to see a slight improvement.

* SG view Following the publication of FY15 results, we have cut our EBIT forecasts by
c.6% on average for 2016-18e. This is mainly driven by more unfavourable forex
assumptions (in particular for Argentina and China) and more caution on Asia due to
difficulties in China (where management sees growing losses in 2016e vs 2015). That said,
we continue to see a compelling story that is still undervalued by the market, with: 1) The
start of a promising new phase. The group is already preparing to accelerate the rollout of
its multi-format strategy (store openings and tactical acquisitions). 2) An acceleration in
organic growth and plenty of potential margin leverage. 3) A likely jump in FCF. 4) An
attractive valuation with a 2017e P/E ratio of 12.7x vs 15.7x for the sector average.

* How we value the stock We have cut our TP from €38 to €35 to reflect our estimates cut.
Our TP is the average of a DCF (€36 vs €37.2, WACC of 8.3% vs 8.0%, unchanged
perpetuity growth of 1.5%, unchanged norm. EBIT margin of 4.0%) and a discounted SOP

* Events, catalysts & risks to price target, rating & recommendation Q1 16 sales on 15
April 2016. Risks to price target, rating & recommendation: Execution setbacks on Dia
France’s integration and difficulties improving profitability (SGe DIA EBIT, -€60m 2016e, €0m
2017e); fiercer price competition in France, driven by Leclerc and/or Auchan; further
deterioration in Brazil (14% of group sales in 2015 – all else equal, a 100bp erosion in the
EBIT margin in Brazil reduces total group EBIT by c.5%); failed turnaround in China (7% of
total group sales).

>>> Street Pre-Market Indications

ML
DE LA RUE - FY op profit expected to be £62m v £55.5m cons. FY16 reit..+5-10%
ELEKTA - Richard Hausmann joining in May & becoming new CEO as of June....+5%
SOFTWARE AG - Beat. Prelim 1Q Rev EU 206.2m v EU 197.6m, +2% after-hrs..+2-3%
TELFORD HOMES - Expect PBT to be slightly ahead of current expectations.+2-3%
TESCO - Solid. UK LFL for Q4 +0.9%. Op profit 2% beat. Short interest 7%+2-3%
COUNTRYSIDE - Very positive H1 update & expects to make progress at FY..+2-3%
AXA - In talks to sell Axa Wealth in deals that may raise £500-700mn....+2-3%
WH SMITH - Good. PBT beat, £80m for the 6m is better than cons of £78mn...+2%
HALFORD - LfL numbers beat on all metrics. On track for pretax of £78-82m.+2%
JUPITER - Net inflows £723m v £400m cons. Total AUM 2% ahead of BAML est..+2%
THYSSEN - More spec around deal with Tata. Planning to sell CSA in Brazil.+2%
H&M - Stefan Persson (Chairman & largest SH) purchases 3.28m shrs ($117m).+2%
SANOFI - Spec Medivation (+9% a/hrs) rebuffed t/over approach from Sanofi.+2%
ROBERT WATERS - Q1 net fees +9%, solid start to the yr. HAS reports tmrw..+2%
VESTAS - To supply wind turbines for a 600 MW project in US contract......+1%
DANONE - Appointing Heller (ex Kraft, J&J) as head of Early Life Nutrition+1%
ASTRAZENECA - Rival drug Rociletinib receives -ve vote from FDA panel.....+1%
LEG - Acquiring 1,100 units, EUR 53mn consideration (inc EUR 20mn debt)...+1%
LOGITECH - To buy Jaybird for $50m, expanding into fast growing wireless..u/c
SEGRO - Finance Director Justin Read to retire later this year............u/c
ATK - Expects FY inline with exp, shrs recovered well from Feb lows.......u/c
HUNTING - Rev YTD -50%, and profits are set to be low as expected.........u/c
CS
Autos +1-2% Asia strong, Euro back below 1.14
Berkeley +1-2% Won approval to develop as many as 652 homes
De La Rue +6-8% Sees higher FY operating profit than epected
Diageo +1% CS reiterate OUTPERFORM post roadshow
Gerresheimer +1% Q1 Sales 0.5% miss, EBITDA 0.7% miss, confirmed FY16
Halfords +1-2% No's slightly better, Says on track to meet profit for FY
Hella -1% Q3 EBIT 6% miss, revenues 2% miss, reiterates FY
Jupiter +2-3% Net inflows of £0.723b better, AuM of £36.2b (CSe 35.5b)
Logitech M/P To buy Jaybird for $50m
Miners +2% Copper +1.70%, Brent +0.15%, Iron Ore +1.70%, China +2.35%
Mittal +3-4% CS upgrade to OUTPERFORM (Cycle recovery)
Oils +1% Spec Russia/Saudi reached consensus on an oil output freeze
Rob Walters M/P Q1 gross profit 59m vs cons 59.9m, FY unchanged
Software +2-3% Positively pre-announced, revs 4% beat, reiterated FY
Stan Life +1-2% Spec Standard Life is bidding for Elevate, Axa’s platform
Tesco +2% Profit ex items 944m vs 940m, UK lfl 0.9% cons -1.9%to+1.5%
WH Smith M/P Pretax a tiny bit ahead, dividend slightly better
WS Atkins M/P Traded well through Q4, sees FY inline
Commerzbank:
ALV +0.5% JPM cuts to Neutral (Overweight) – PT €175 ECX +26.5% Gets FDA approval for Epi Procolon Cancer Test HLE –0.9% Results slightly below exp and unchanged guidance GXI +1.9% Q1 below, guidance in line LEG +0.1% Buys portfolio worth €53mn LNSX -0.4% DZ Bank starts with Buy - PT €22.5 SAZ +0.4% CBK ups to BUY (Hold), PT €44 (32), valua not reflecting better CF SHA +1.3% HSBC reinitiates with BUY and a PT of€18 SNH +0.1% FNAC is studying a possible new offer for Darty SOW +0.2% Excellent Q1 due to “old” business, digital disappointing SPR –0.1% To invest more cash in Retale this year
SRT3 +0.7% HSBC raises to Buy (Hold) – PT €275 (256) TLX +0.2% Plans to cut 330 jobs at HDI sales unit by 2020 TKA +1.1% ThyssenKrupp, Tata said to weigh IPO of merged steel units
MainFirst Pre Mkt Indications
*GLAXO-Expects positive FX impact on Q1 sales around 2% to 3%......+0.5%
*AIR FRANCE-Offer viewed unfavorably by pilots says Les Echos......-0.5%
*SANOFI-Medivation has rebuffed takeover approach from Sanofi......U/C
*TESCO-FY OP 944m(936),Sees profit improvement in H1...............+2%
*SOFTWARE-Q1 Rev 206.2m(197.6),Ebit 45.3m(38.28),take profits......+1%
*VESTAS-Conditional deal for 600 MW project in USA-Not Firm........+0.5%
*LEG IMMOBILIEN-Buys portfolio worth €53m..........................U/C
*GERRESHEIMER-Sales 342.3m(342.4),Ebitda 66m(63.8),EPS 74c(67).....+1%
*DASSAULT AVIATION-CEO hopes 2 sign India Rafale deal soon(again)..U/C
*HELLA HUECK-Rev 1.5b(1.52),Ebit 89m(95),NI 53m(63),o/l ok ish.....-1%

WSJ : Nestlé Develops Foods to Treat Diseases

Nestlé Develops Foods to Treat Diseases

Prescription-based powders, drinks become a new focus as traditional packaged foods face tougher times

LAUSANNE, Switzerland—In a corner of a technical research university campus in Lausanne, Nestlé SA scientists are untangling genetic profiles to develop medical foods—one of the company’s big hopes for sales growth.

​These aren’t the high-energy protein bars that people buy over the counter before a workout. Instead, the Swiss food company is tapping into an estimated $15 billion market for prescription-based powders and drinks intended to meet specific nutritional requirements to treat diseases.

For Nestlé, it’s a market with big potential, amid an aging global population, as the company navigates tougher times in its traditional packaged-food market. Sales of frozen pizza and ice cream have struggled. It has missed its sales-growth target of 5% to 6% three years running.

On Thursday, the company is expected by analysts to report sluggish sales growth for the start of 2016.

“For a long time, nutrition has been seen as a sort of pseudoscience,” said Ed Baetge, head of Nestlé’s Institute of Health Science, or NIHS. “For many conditions like age-related dementia, for example, there is a major clinical need for new approaches, and where food can make a big difference.”

But for skeptics, the sector is a Wild West with uncertain benefits.

Unlike dietary supplements, medical foods are intended for people with chronic diseases rather than for healthy people. They must be used under medical supervision because they are intended to manage serious illnesses, like Alzheimer’s.

The products have active ingredients derived from food products or dietary ingredients that are generally recognized as safe by the U.S. Food and Drug Administration.

In a basement of the Nestlé institute’s four-story office building in Lausanne near Lake Geneva, machines costing nearly $1 million each analyze human DNA to develop personalized programs for conditions like epilepsy and intestinal disorders that are tailored to specific genetic profiles.

Armed with this knowledge, the scientists will develop medical foods containing natural compounds extracted from foodstuffs like tomatoes, coffee and grapes.

Set up five years ago, the institute is halfway through its $500 million budget, which runs to 2021, although it has projects that extend beyond then. And Nestlé has been on a U. S.-focused acquisition spree.

Earlier this year the company signed a deal to help U.S. biotech company Seres Therapeutics Inc. develop products aimed at restoring bacteriological balance in the digestive system. It also bought a stake in Pronutria Biosciences Inc., a Cambridge, Mass., startup developing amino acid-based products to treat muscle loss.

Demographic trends seem to support these investments. The proportion of people over 60—a key group for medical foods—is forecast by the World Health Organization to rise to 22% globally by 2050 from 12% at present.

“We want to have a significant impact on the company’s overall profitability over the long term,” said Greg Behar, who heads Nestlé’s Health Science business, which markets products developed from findings at the institute’s labs.

Analysts are generally upbeat about the potential of Nestlé’s health business, which also includes nutritional supplements and foods for people after surgery, saying it grew faster than the rest of the company’s operations in 2015 to post sales of about 2 billion Swiss francs ($2.1 billion). Nestlé aims to increase that amount to 10 billion francs in the next few years. ​​

But there are concerns about the time needed to bring such products to market and the hefty research costs.

Although medical foods don’t need premarket review and approvals like drugs, they must be based on what Nestlé calls “sound medical and nutritional principles,” ​and the FDA subjects​them​to monitoring. ​

Not all experts are convinced. “While it’s clear that what we eat and drink has a substantial effect on our health, there is currently insufficient evidence documenting that these foods provide a medically relevant effect,” said Ben Locwin, a scientist who works with the American Association of Pharmaceutical Scientists.

Many products may have a placebo effect with consumers “thinking” they benefited when they hadn’t, he said, calling medical foods the “Wild West” of the industry with many new entrants.

Dr. Philip Gerber, a specialist in clinical nutrition at University Hospital Zurich, has used medical foods more in the last few years, but needs more data. ”I am not sure we will see a huge exploding market here; these products have to prove how effective they are.”

Nestlé said that before market introduction, studies must be conducted showing that its products are safe, beneficial and effective in meeting the nutritional requirements of patients.

In addition, some of its products, like one being developed to help remission of inflammatory bowel disease, are being developed through the conventional trials process.

“It is very important for us to have clinical evidence,” said Nestlé Health Science spokeswoman Marie-Françoise Rütimeyer.

Still, patient groups welcome the initiative.

“I don’t care if it’s traditional pharmaceuticals or a medical food,” said James Hendrix, director of global science initiatives at the Alzheimer’s Association in the U.S. “There is a huge unmet medical need.”

(IlSole24Ore) Padoan: decisive steps for the revival of banks



Google Translation

"The measures taken by private investors fund Atlas and measures of the Government on bankruptcy law will be crucial for the revival of the banking system." With soft tones, but decided that distinguish it, the Minister Pier Carlo Padoan not seemed worried doubts emerged yesterday among investors ( "in the past few days, perhaps there had been too much enthusiasm"). The plan "is an approach favored by the ECB Banking Supervision", while Padoan sees "no risk" stop by the EU to fund Atlas' fueled by private capital, with voluntary contributions, and managed by private entities. " In the first interview of 2016, Padoan talks to Sole 24 Ore also the Def: for privatizations, the MEF think of another tranche of Poste, while "the reduction in the tax burden must be done with spending cuts." Padoan bets on the yes of the EU to Def and flexibility. Cutting for the voluntary disclosure "if it works, you can still use it."

Minister Padoan, to overcome the fragility of the banking system, government and private financial system have developed a comprehensive system of measures for the revival of the sector. How did it come to this change?
This is an operation that involves the private sector, with an intervention that takes place in parallel to the new measures that the Government will approve in the Council of Ministers next week to speed up bankruptcy and insolvency procedures.

What role did the government, particularly the Ministry of Economy, in the birth of the fund Atlas privately held?
The MEF and the Government played a role that I would describe as a facilitator. The fund will be managed by a private asset management company and will be funded by private capital on a purely voluntary basis. It will have two main objectives: to contribute to some bank recapitalisations, with functions and backstop of last resort safety net, and set up a mechanism of buying and credit management in suffering, just as market participants operating in the sector , also uses the leverage expanding the range compared to the paid capital.


Of 5-6 billion that should be collected from the bottom, how many will be destined to the guarantee of the capital increases and how the purchase of bad loans?
The rules for allocation of the fund will depend on the needs and market acceptances of several recapitalisations.

The stock market, after two days of euphoria, yesterday investors' doubts have emerged. He believes that the dual plan will work?
In recent days there has been much hype, perhaps even too much to be concentrated in just two days. The markets do not yet have a complete picture, since the fund's launch has just been announced, and this lack of information results in nervousness. Moreover, the markets will want to assess not only the base but also the new measures of the government, which I consider crucial to permanently deal with the problem of suffering. The new measure will complete the reforms already carried out by the Government. This is an important step which fills a delay of Italy than in other European countries.

How much does the problem of bad debts on banks' ability to extend credit?
I am the first to admit that the vulnerability of the system due all'ingente stock of bad loans is a problem that is there and needs to be addressed. The government has already intervened in recent months with a series of measures, and the next will be decisive. We are working with Minister Orlando to anticipate by decree certain provisions contained in the enabling act before Parliament in the field of bankruptcy law. If the times of disputes on loans is more than halved, the market value of the credits in suffering it has a benefit. Solved the problem of bad debts will share real economy. I add that the removal of part of the stock of loans from bank balance sheets will also increase the effectiveness of monetary policy of the ECB for Italy.

It is a problem that could be addressed before?
Other countries, including Spain, have done it years ago with public capital. Since August 1, 2013 the European rules are stopping us.

About rules, the fund is likely to be plan Atlas rejected by the EU commission and the European supervision of the ECB?
I do not see any risk. From the point of view of competition law can not presence there any role given that the state, the transaction is entirely private: a private asset management company that creates a fund with private capital on a voluntary basis. With unique monitoring of the ECB is already an ongoing fruitful dialogue conducted by the Bank of Italy and from Frankfurt there is a very constructive attitude, I think they see welcome this initiative.

Too many rules imposed by the rapid deployment Banking Union? What do you think of the German proposal to limit the weight of government bonds in banks' balance?
Italy is among the supporters Banking Union, but we request that you now complete, as planned, with the third pillar, which provides for the guarantee of European deposits. The proposal to limit government securities on bank balance sheets is wrong and damaging Italy's judgment because it introduces elements of rigidity in a market in which instead must be free to diversify investments. And in any case, we believe that the issue should not be addressed at European level but at a global level and in the institutions responsible for doing so such as the Basel Committee.

2015 was the year of the return of foreign investors in our country. He believes that the confidence is still there or you're fading? And the package of measures on banks may contribute to the confidence of investors?

The banking system is a delicate junction. There are efficiency issues of individual banks and systemic factors. The measures that were taken reinforce the perception of confidence in the banking system and the country's stability. More generally, investor sentiment towards Italy remains positive. It was of interest in anticipation of the promised reforms, was approved when the reforms were enacted, will support now that the reforms are implemented.

In the decree there will be provisions for compensation to bondholders junior of 4 banks whose bankruptcy was decreed? I think that's the correct context.

The Def confirms its objective of revenue from privatization in 2016 amounting to 0.5% of GDP, despite the loss of the FS quotation.
Harnessing public enterprises is not just about selling a piece of the state to raise cash for the purpose of killing of debt but it also means exposing the management of the competition and the scrutiny of the markets to improve outcomes and quality of services. This applies to Poste, Fs, ENAV.

But how will replace in 2016 the revenue was expected at Fs? There are still areas of improvement, even for the same post office. The ability to control by the shareholder can you guarantee with a share of lower participation, as in the case of Eni and Enel.

So you are thinking about the placement of additional shares Poste market?
It's a possibility, anyway always maintaining control.

Growth remains the priority objective of the government despite the slowdown?
The growth of 2016 will be for Italy to 50% higher than that recorded in 2015, from 0.8% to 1.2%. It is less than what we would like, but the growth rate was affected by the deterioration of the economic situation in the US and Europe, with the slowdown in investment and international trade. Even in Italy the contribution to the growth of exports is much lower than that of investment and consumption.

There are factors on which bets to strengthen growth in the coming months?
First of all, investment, private and public, which are a component of demand in the short term but also a factor of development and competitiveness in the medium term. To unlock public investments have exceeded the internal stability pact, and even push private investment have a new package of financial measures for growth.

What is it?
Last year we did a lot on the regulatory plan to move the Italian enterprises to the capital market and thus rebalance the funding system too bancocentrico. We gave incentives for investments and recapitalizations, looking always to the company. Now we shift the focus on the investor firm with incentives also important, for example for funds that invest in small and medium-sized enterprises. We want to move a proportion of savings run to the Italian company. This can bring foreign capital to the Italian companies.

Data that you have on public investment? You are releasing something?
The first results are there. Italy is among the first countries in the use of resources Bei Juncker bottom and it was not easy to start this mechanism. And then come back to the municipalities to invest due to the overcoming of the domestic stability pact that when I started doing this work, I immediately became a bureaucratic monster.

You have begun to define the context of the forthcoming Stability Law in the fall. Remains the boulder of safeguard clauses more than 15 billion that you want to remove. Remain resources for growth and stimulate investment?
The Italy's consolidation effort places our country among the best performing in Europe, and we must continue to bring down the debt. So the fiscal space, under equal conditions, is limited. It becomes important to decide how to use it.

We are the first proposals: the prime minister speaks of extension of 80 euro to the lowest pensions.
At this stage there are various hypotheses on the carpet. It is early to say.

The reduction in the tax burden remains one of your goals?
It is one of the pillars of government policy, but as I often say, to be credible must be financed by spending cuts. This is why the spending review continues.

Here too there is a widespread perception that the spending review has stopped or even there's never been.
It is not true. This year's spending review was 25 billion thanks to the law of stability and the measures taken in the preceding months. Equally important are new mechanisms that we are starting to structurally change the spending, such as the centralization of purchasing in health care, where spending centers fell by 33 thousand to 35. Or the reform of the budgetary procedure. Starting in 2017 we will have a permanent spending review that forces you to review not only the costs at the margin but to think back on all spending. With the result of giving more flexibility to the budget.

Slippage of the tie to 2019 has already agreed with Brussels? The measures that are in Def have been discussed by the government but also shared with the commission, which has yet to rule on the built-in flexibility in Def.

He is confident on the approval of the Def and flexibility by the EU Commission?
I do not think there will be problems. The Def does not come to the committee on the table as well, but again, we discussed it, even acknowledging some observations. The Italian position is that the macroeconomic framework that is in Def is absolutely compatible with European rules. The displacement of a balanced budget is consistent with the international framework deteriorated. And then the fiscal adjustment is related to the method used to calculate the structural balance, a technical issue but with serious political implications for the lives of citizens. Italy moves between Scylla and Charybdis. On the one hand if you do too much restriction, it generates a dynamic of debt that gets worse rather than better. On the other hand if you do not take into account the objective of debt reduction, market expectations and thus worsen the country's costs for market funding increase. The path is narrow but we continue to follow him.

Change towards Europe. Where are we?
My feeling is that relations with Europe are much improved, and the dialogue is more constructive, at least in the field of fiscal and competition policies. It is recognized that Italy continues to work and make decisions that are within the rules. To those who say we are asking too much flexibility I have answered many times: we ask the flexibility allowed by the rules. This more constructive relationship with the European institutions is the result of an attitude that at some stage it seemed only aggressive and that instead it is of substantial proposal. Since the presidency we said that Europe had to give different priorities, growth and employment. This has translated into facts, such as flexibility. And recently we made ​​a strategic proposal that is being discussed with great attention. Italy is definitely not cramped in a corner. It is seen as an important country in which there remain problems that the government is facing.

Flexibility pensions in output. It is premature to talk about it?
Our pension system is among the strongest in Europe, and this strength is a value that must be protected because it contributes to the sustainability of public debt. The pension system can be improved, even for the implications that some changes might have on the labor market in terms of employment of young people. We are still in the initial phase of the discussion but the important thing is that we take into account the public finance constraints.

That suggests the publication of papers Panama?
As for Italy, I confirm that we are a country at the forefront in the fight against tax havens. At the same time the Panama Papers show that there are still many blacks holes in the international fight against tax evasion, especially in terms of localization of corporate structures. We take initiatives in international fora, both formal and informal, such as the G5 of which Italy is part with France, England, Spain and Germany. It must first be emphasized the firmness in the fight against tax evasion by reinforcing existing international cooperation. It serves a cooperation which provides rapid exchange and analysis of the joint venture, even to get to real joint audit between tax authorities of different countries. It can also improve the transparency of beneficial owners of accounts and financial products, going to all the people that own checking and exchanging such information also for tax purposes.

Do you plan to reuse the instrument of voluntary disclosure? Domestically we are doing a "coupon" to the voluntary disclosure mechanisms to understand what results he produced and whether there are still room for use. If a machine is working and there are still kilometers to go, you can certainly use again.

>>> What to look at today - 13th of April 2016

Dow+0.94% S&P+0.97% Nasdaq+0.80% Russell+1.04% VIX 14.85 -8.67%
US Market closed higher helped by Oil rally. WTI crude climbed 4.1% ($42.12/bbl) before the end of its pit session, high for 2016 and a gain of 14.5% week to date. By the end of the day, all ten sectors were in the green with energy (+2.8%), financials (+1.3%), and materials (+1.2%) leading the advance. IMF lowered its 2016 growth estimate for the global economy from 3.4% to 3.2%. Meanwhile, mixed results in Alcoa's (AA 9.48, -0.26) first quarter earnings report also acted as a headwind. The company missed top-line expectations as revenue shrank 15.0% year-over-year. Volume were above average with 951mil shares. US After Hours MDVN+9% on news of Sanofi takeover approach, VRX -2% after report that a bondholder intends to call default on Co, RPRX +65% after positive clinical data; PTIE +6.7% on FDA News. Risk appetite on display in US hours that was fanned by dovish comments from Feds Kaplan and recovering inflation prints in Europe has carried over to Asia, where Chinese trade components signify some improvement in global conditions. Although the terms of trade missed expectations, China exports rose for the first time in 9 months while the decline in imports was much less than expected in both CNY and USD term. Flows from US bonds into equities has helped the dollar to recover against Japanese Yen - a relief to some of the recent worries in Tokyo about adverse FX volatility.

Nikkei +2.77% Hang Seng +2.43% Shanghai +2.22%

Eur$1.1360 CNH 6.4759 CNY 6.4665 JPY 108.87 GBP 1.4237 CHF 0.9576 RUB$ 65.5247 WTI$ 41.63 (-1.26%)

S&P+0.24% EuroStoxx+1.36% Dax+1.22% SMI+0.83%

Macro :
U.S. March Budget Deficit at $108b; Est. $104b
Fed’s Lacker Sticks With Gradual Pace; Case for Hikes Is ‘Clear’
- Regulators Set to Find Flaws in Big U.S. Banks’ ‘Living Wills’, J.P. Morgan, other firms, set to receive not credible verdict from Fed, FDIC - WSJ - http://on.wsj.com/1Wqr0qc
-
Inversion Rules May Be Done by Labor Day, IRS’s Koskinen Signals
- China’s March Exports Rise 18.7% Y/y in Yuan
- ECB Sees Italy Bank Rescue Fund Favorably: Padoan in Sole

Keep an eye on :
- ABI BB : Anheuser-Busch InBev Controlling Holders Extend Pact 10 Years
- AF FP : Air France Offer Viewed Unfavorably by Pilots, Les Echos Says
- SPR GY : Axel Springer Said to Invest More Cash In Retale This Year: WSJ
- BOL FP : Bollore Offices Searched in Connection to African Ops: Le Monde
- CA FP : Brazil Stocks ETF Rises 3.1% in Tokyo, Set for August High
- CSGN VX : Credit Suisse May Need to Strengthen Board: Herro Tells FuW
- BN FP : Danone Says Bridgette Heller to Joins Executive Committee July 1
- AM FP : Dassault Aviation CEO Hopes to Sign India Rafale Deal Soon
- EDEN FP : Brazil Stocks ETF Rises 3.1% in Tokyo, Set for August High
- FB US : Facebook L-T Focus Is on Connectivity, AI, Virtual Reality: CEO
- FNAC FP : Fnac Is Studying Possible New Offer for Darty, Le Figaro Says
- GXI GY : Gerresheimer 1Q Adj. Ebitda, EPS Beat Estimates; Keeps Forecast
- HMB SS : H&M Chairman Stefan Persson Has Bought ~3.28m H&M Shares
- IAG LN : IAG CEO Says U.S. Airports Actively Seeking Aer Lingus Flights
- LIAB SS : Lindab Chairman Declines Re-Election After Media Links to Panama
- LHA GY : Lufthansa May Take Control of Brussels Airlines: Sueddeutsche
- RCS IM : RCS: creditor banks to meet Urbano Cairo over Cairo Communications' public offer - Il Sole 24 Ore
- REP SM : Repsol Trying to Finalize Vietnam Gas Deal: Business Times
- SCYR SM : Sacyr Says It Could Recover $614m From Panama Canal Claims
- SAN FP : Medivation Said to Have Rebuffed Takeover Approach From Sanofi
- SIKA VX : Schenker-Winkler: Sika Board Again Imposed Illegal Restrictions
- GLE FP : France to Study Whether SocGen Helped Conceal Clients Offshore
- SOW GY : Software Ag Preliminary 1Q Rev. EU206.2m, Est. €197.6m
- TIT IM : Telecom Italia Won’t Replace Ex-CEO Patuano on Board
- TKA GY : ThyssenKrupp, Tata Said to Weigh IPO of Merged Steel Units: RP
- TSCO LN : Tesco Believed to Be Considering Sales of Domestic Units: FT
- VRX US : Big Valeant Bond Investor Notifies Company of Intent to Call a Default, Investor Centerbridge cites delay in drug maker’s filing of its annual report -WSJ - http://on.wsj.com/22svood
- WTB LN : Costa Coffee MD’s exit dampens talk of Whitbread break-up - FT

>>> Europe : Brokers Upgrades * Downgrades - 13th of April 2016

>>> Up
*ARCELORMITTAL RAISED TO OUTPERFORM VS NEUTRAL AT CREDIT SUISSE
*AXA RAISED TO OVERWEIGHT VS NEUTRAL AT JPMORGAN
*CNOVA RAISED TO OVERWEIGHT VS NEUTRAL AT JPMORGAN
*COBHAM RAISED TO OVERWEIGHT VS EQUALWEIGHT AT BARCLAYS
*EURONEXT NV RAISED TO BUY, ADDED TO CONVICTION LIST: GOLDMAN
*PLA ADMINISTRADORA RAISED TO OVERWEIGHT AT JPMORGAN
*SARTORIUS RAISED TO BUY VS HOLD AT HSBC
*VESTA RAISED TO OVERWEIGHT AT JPMORGAN

>>> Down
*ALLIANZ CUT TO NEUTRAL VS OVERWEIGHT AT JPMORGAN
*APARTMENT INVESTMENT CUT TO NEUTRAL AT ROBERT BAIRD
*AUTOLIV INC. CUT TO UNDERPERFORM AT RBC CAPITAL
*GN STORE NORD CUT TO HOLD VS BUY AT HSBC
*INDITEX CUT TO UNDERWEIGHT VS EQUALWEIGHT AT BARCLAYS

>>> PT Change


>>> Initiation
*AXACTOR RATED NEW BUY AT DNB MARKETS, PT NOK3
*B&M RATED NEW BUY AT LIBERUM, PT 300P
*CELLNEX RATED NEW BUY AT JEFFERIES, PT EU16
*DIXONS CARPHONE RATED NEW BUY AT LIBERUM, PT 510P
*EI TOWERS RATED NEW HOLD AT JEFFERIES, PT EU55
*H&M RATED NEW HOLD AT LIBERUM, PT SEK275
*INDITEX RATED NEW BUY AT LIBERUM, PT EU37
*LVMH RATED NEW HOLD AT LIBERUM, PT EU150
*MARKS & SPENCER RATED NEW SELL AT LIBERUM, PT 350P
*POUNDLAND RATED NEW HOLD AT LIBERUM, PT 160P
*RAI WAY RATED NEW HOLD AT JEFFERIES, PT EU5
*SCHAEFFLER RATED BUY AT HSBC, PT EU18; WAS RESTRICTED

>>> Call
*INCHCAPE ADDED TO EUROPEAN ANALYST FOCUS LIST AT JPMORGAN